Foto de portada de Bayer
Bayer

Bayer

Fabricación de productos químicos

Leverkusen, North Rhine-Westphalia 5.834.784 seguidores

Sobre nosotros

Bayer is a global enterprise with core competencies in the life science fields of healthcare and nutrition. We design our products and services to serve the most essential human needs of health and nutrition. At the same time, we strive to address some of the world’s biggest challenges presented by a growing and aging global population. At Bayer, we’re committed to driving sustainable development and generate a positive impact with our businesses. Through the power of science, we’re pioneering new possibilities that advance life for all of us. That means reimagining how we care for ourselves and one another by empowering everyday health, improving approaches to patient care, and finding better ways to nourish our communities around the world. Data Privacy Statement & Imprint: https://www.bayer.com/en/glob-li-bayer-en-dps-imprint.aspx

Sitio web
https://www.bayer.com/
Sector
Fabricación de productos químicos
Tamaño de la empresa
Más de 10.001 empleados
Sede
Leverkusen, North Rhine-Westphalia
Tipo
Empresa pública
Especialidades
Pharmaceuticals , Consumer Health, Crop Science, Life Sciences, Research, Innovation, Sustainability, Health Care, Digital Farming, Food Security, Science For Better y Innovation

Ubicaciones

Empleados en Bayer

Actualizaciones

  • At Bayer, we live by our mission: "Health for all, Hunger for none." Our sustainability goals are an integral part of our business strategy, as we believe in the value they provide to those we serve – from farmers to patients to consumers around the world. In 2024, we made great progress with our "100 million" goals: 🌎 51 million women in low- and middle-income countries gained access to modern contraception. 🌎 73 million people in underserved communities received self-care solutions. 🌎 52 million smallholder farmers received support in developing regions. Here are some more highlights from the year: • 🌱 We were recognized for our Climate Transition and Transformation Plan. This plan outlines our path to reduce our carbon footprint, with a goal to achieve climate neutrality by 2030 and reach Net Zero emissions by 2050. • 🌾 We made progress in enabling regenerative agriculture and expanding our biofuels footprint, reinforcing our role in transforming food and farming systems. • 💊 We launched the Global Health Unit, with the goal to improve access to essential medicines and healthcare in areas that need it most. • 📈 We continue to include our sustainability goals in our long-term plans, to ensure that caring for the planet is part of our business success. In short, we’re making great strides towards achieving our targets. A big thanks to everyone at #TeamBayer for their hard work and commitment to making a difference! Together, we can create a better future!

  • Ver la página de empresa de Bayer

    5.834.784 seguidores

    Are you ready to take the next step in your career? Bayer is seeking motivated individuals for our Leadership Development Program (LDP) in Germany. This program is designed to develop future leaders by providing hands-on experience, mentorship, and exposure to various business functions. Are you curious? Watch the full-video: http://spr.ly/6048F0YGa ... and apply here: http://spr.ly/6040F0YGI #BayerCareer #BeBayer #TeamBayer Timilehin Ayodeji, Diana Talledo, Abhinav Singhvi, Lukas Tanzmayr

  • Ver la página de empresa de Bayer

    5.834.784 seguidores

    What is better than one potential new treatment option for Parkinson’s Disease? TWO! Bayer has achieved something unprecedented: We’re the first company with investigational cell AND gene therapies in the fight against #ParkinsonsDisease. Where we stand: ✅ Our investigational cell therapy and gene therapies for Parkinson’s received Regenerative Medicine Advanced Therapy designation from the FDA ✅ Our investigational cell therapy for Parkinson’s is advancing into Phase III ✅ Our investigational gene therapy for Parkinson’s is currently in Phase II What this means for patients: People with Parkinson’s disease still face medical unmet needs, which only worsens as the disease inevitably progresses. We’re striving to change this by developing new innovative treatments aimed at changing the course of the disease. These advancements in the development phase are a huge step forward towards making these treatments a reality for patients. We’re not doing it alone: 🚀 Our innovative work together with AskBio Inc. and BlueRock Therapeutics is aiming at pushing the boundaries of what's possible in Parkinson's treatment. We strive to make a tangible difference in the lives of people with Parkinson’s, so we're going to keep pushing forward! Where we’re headed: 💙 This milestone reflects the passion and dedication of #TeamBayer, working tirelessly to transform lives through groundbreaking science. We're not just developing treatments; we're working to provide hope for patients with Parkinson's Disease. Together, we're making science for a better life! Want to learn more about this exciting news? Visit: https://lnkd.in/e8XtvzUb #InnovateForPossible

  • Ver la página de empresa de Bayer

    5.834.784 seguidores

    At Bayer, we are rethinking talent development: We believe in flexible, skill-based development – giving our employees the chance to grow, explore, and move across the organization in new ways. Instead of fixed career paths, we focus on expanding capabilities and fostering individual learning journeys. Want to take charge of your career? The new Talent Marketplace is here! This platform helps employees discover new opportunities – from internal jobs to project-based experiences, networking, and skill-building. Your career, your way. Start now! https://lnkd.in/gWEXm2Ju #BeBayer #BayerCareer #TeamBayer #TalentMarketplace #HeikePrinz

  • Ver la página de empresa de Bayer

    5.834.784 seguidores

    At Bayer, we believe that taking time to rest, connect and recharge is critical to long-term performance and well-being. That’s why flexibility isn’t a perk here, it’s woven into our work culture. Whether it’s picking up the kids, going for a refreshing walk, or simply having a quiet moment to yourself, we empower our employees in structuring their workday around what matters most to them. Because at Bayer, ambition and presence go hand in hand. What helps you to log off with a clear mind? Share your routine in the comments! #BayerCareer #BeBayer #TeamBayer #WorkLifeBalance #Flexibility #Wellbeing #ThisAnd

  • Ver la página de empresa de Bayer

    5.834.784 seguidores

    #TeamBayer is committed to driving innovation and making a meaningful impact on global health. As part of our ongoing transformation, we are redefining how we approach R&D and growth across key therapeutic areas, including oncology, cardiovascular diseases, and women’s health. By leveraging cutting-edge technology and fostering collaboration, we aim to accelerate medical breakthroughs while ensuring sustainable business growth. With a focus on innovation and R&D excellence, Bayer is shaping the future of healthcare for patients worldwide. #PharmaMediaDay #PMD25

  • Ver la página de empresa de Bayer

    5.834.784 seguidores

    In our latest episode of Science Is Boss, we tackle menopause and the critical need for hormone-free treatments for hot flashes. Join CEO, Bill Anderson, external communications director Nicole Hayes, and Yesmean H. Wahdan, MD, the U.S. VP of Medical Affairs, as they explore the innovative approaches our team is taking to develop effective solutions that empower women to reclaim their comfort and confidence.

  • Ver la página de empresa de Bayer

    5.834.784 seguidores

    For Jorge Molina Lopez, the Talent Marketplace has been a game changer. It’s more than just a platform – it’s an opportunity to take ownership of your career, explore different areas at Bayer, and connect with like-minded colleagues. From discovering new skills to building meaningful connections, the Talent Marketplace reflects the openness and inclusivity we strive for at Bayer. It empowers employees to shape their own path, no matter their background or current role. Find out more about the Talent Marketplace: https://lnkd.in/gAK23ZvN Be empowered. Be Bayer. #BeBayer #BayerCareer #TeamBayer #TalentMarketplace #TalentDevelopment

  • Ver la página de empresa de Bayer

    5.834.784 seguidores

    By 2030, more than 1 billion women will be in menopause. Menopause can substantially affect a woman’s life, but a lack of awareness and care options leaves most symptoms untreated. Each woman’s experience with the menopause transition will be different. Menopause usually begins during a period where women are at the peak of their life’s activity and can affect them both at home and in the workplace -- and it is much more than JUST hot flashes. In fact, the most commonly reported and bothersome symptoms during the menopausal transition are hot flashes, sleep disturbances, and mood changes. From developing therapeutic options that address menopause symptoms to global physician education efforts, we’re actively broadening women’s options for care that help them maintain their health and quality of life through this transition. And this is how: 📄 Trialing a new hormone-free treatment 🌙 Exploring treatment for sleep disturbances 🌟 Offering science-backed products, including nutritional supplements and intimate care solutions 🌐 Bringing awareness and education efforts to women and physicians globally

    • A graphic featuring a gradient background with shades of dark blue and pink. In the center, there is a text that reads: 'Think menopause is just hot flashes? Think again.' The design includes soft circular shapes in varying sizes and opacities, adding a modern and artistic touch.
  • Ver la página de empresa de Bayer

    5.834.784 seguidores

    Μια χρονιά ορόσημο για τον Τομέα Φαρμάκων της Bayer Pharmaceuticals! Κατά τη διάρκεια της ετήσιας εκδήλωσης για τους δημοσιογράφους “Pharma Media Day”, παρουσιάσαμε τις σημαντικές εξελίξεις στη στρατηγική μας για μακροπρόθεσμη ανάπτυξη, στο πλαίσιο της συνεχιζόμενης αναδιαμόρφωσης του Τομέα Φαρμάκων της εταιρείας μας. Με την αφοσίωσή μας στην καινοτομία, την έρευνα και την επιστήμη, ανταποκρινόμαστε στις ανεκπλήρωτες ανάγκες των ασθενών παγκοσμίως και χτίζουμε το μέλλον της υγείας για τις επόμενες γενιές. https://bit.ly/3Rnvv7v #bayer #teambayer #BayerHellas #betterdaybetterlife #healthforall #hungerfornone #PharmaMediaDay #PMD25

    • No hay descripción de texto alternativo para esta imagen

Páginas asociadas

Páginas similares

Financiación

Bayer 3 rondas en total

Última ronda

Deuda tras OPV

5.287.810.223,00 US$

Ver más información en Crunchbase